IL10 and COVID-19: Lu et al. suggest that as endogenous IL-10 production increases it might function as an immune activating/proinflammatory agent stimulating the production of other mediators of the cytokine storm and could also amplify the viral sepsis-related hyperinflammation observed in critically ill COVID-19 patients [18,19].